Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series

por REPETTO, Federica, BURZI, Lorenza, RIBERO, Simone, QUAGLINO, Pietro, DAPAVO, Paolo
Publicado 2022

Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs

por Burzi, Lorenza, Repetto, Federica, Ribero, Simone, Mastorino, Luca, Quaglino, Pietro, Dapavo, Paolo
Publicado 2022

Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study

por REPETTO, Federica, ROCCUZZO, Gabriele, BURZI, Lorenza, MASTORINO, Luca, DAPAVO, Paolo, QUAGLINO, Pietro, RIBERO, Simone
Publicado 2023

Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost‐effectiveness?

por Roccuzzo, Gabriele, Rozzo, Giulia, Burzi, Lorenza, Repetto, Federica, Dapavo, Paolo, Ribero, Simone, Quaglino, Pietro
Publicado 2022